Human Immunoglobulin G Recognizing Fibrinogen-Binding Surface Proteins Is Protective against both Staphylococcus aureus and Staphylococcus epidermidis Infections In Vivo
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
A human donor-selected immunoglobulin G for intravenous injection (IGIV) product with elevated titers against the staphylococcal fibrinogen-binding MSCRAMM proteins ClfA and SdrG (INH-A21) was tested in vitro and in vivo. INH-A21 contained a significantly increased ability to inhibit the fibrinogen-binding activity of recombinant forms of both ClfA and SdrG. Evaluation of the opsonizing potential of INH-A21 was evaluated using fluorescently labeled bacteria; this assay indicated an increase in phagocytic activity compared to normal IGIV. The prophylactic efficacy of INH-A21 against an intraperitoneal challenge of methicillin-resistant Staphylococcus epidermidis (MRSE) was evaluated in a neonatal rat model. INH-A21 was also evaluated for prophylactic and therapeutic efficacy in a rabbit model of catheter-induced aortic valve infective endocarditis caused by either MRSE or methicillin-resistant Staphylococcus aureus (MRSA). Results from the in vivo models demonstrated potent prophylactic and therapeutic efficacy against both MRSE and MRSA. These data suggest that INH-A21 may be an important tool for the prevention and treatment of staphylococcal infections, especially in high-risk populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 3×
“Staphylococcus aureus and Staphylococcus epidermidis account for over half of all nosocomial bloodstream infections annually in the United States (30).”
BackgroundInfluentialMSCRAMM-MEDIATED ADHERENCE OF MICROORGANISMS TO HOST TISSUES
Patti, J. M., Allen, B. L., McGavin, M. J., & Höök, M. (1994) · Annual Review of Microbiology · doi:10.1146/annurev.mi.48.100194.003101 · Cited by 1,191 · cited 1×
“Some adhesins, known as MSCRAMM (microbial surface components recognizing adhesive matrix molecules), are responsible for the binding of staphylococci to human extracellular matrix proteins and also to surgical implants, such as catheters, artificial joints, and vascular grafts (11, 12, 21 , 22).”
BackgroundSelf-citationSurface-associated proteins of Staphylococcus aureus:Their possible roles in virulence
Foster, T. J., & McDevitt, D. (1994) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1994.tb06828.x · Cited by 186 · cited 1×
“Some adhesins, known as MSCRAMM (microbial surface components recognizing adhesive matrix molecules), are responsible for the binding of staphylococci to human extracellular matrix proteins and also to surgical implants, such as catheters, artificial joints, and vascular grafts (11, 12, 21, 22).”
Background
Cited by
The role of microbial biofilms in prosthetic joint infections: A review
Gbejuade, H. O., Lovering, A. M., & Webb, J. C. (2015) · Acta Orthopaedica · doi:10.3109/17453674.2014.966290 · Cited by 418
Pathogenic Mechanisms and Host Interactions in Staphylococcus epidermidis Device-Related Infection
Sabaté Brescó, M., Harris, L. G., Thompson, K., Stanic, B., Morgenstern, M., O'Mahony, L., Richards, R. G., & Moriarty, T. F. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01401 · Cited by 239
“was shown to reduce mortality in a neonate bacteremia rat model and to decrease bacterial counts in a DRI (endocarditis) rabbit model (Vernachio et al., 2006), although it failed in a clinical trial to prevent late-onset sepsis in low-birth weight neonates (Schaffer and Lee, 2009).”
BackgroundResultXiong, Y. Q., Bensing, B. A., Bayer, A. S., Chambers, H. F., & Sullam, P. M. (2008) · Microbial Pathogenesis · doi:10.1016/j.micpath.2008.06.004 · Cited by 105
“Infective endocarditis was produced in Sprague–Dawley female rats (250–300 g) as described previously [33,34].”
MethodSelf-citationEbert, T., Smith, S., Pancari, G., Clark, D., Hampton, R., Secore, S., Towne, V., Fan, H., Wang, X.-M., Wu, X., et al. (2010) · Human Antibodies · doi:10.3233/hab-2010-0235 · Cited by 50
Pancari, G., Fan, H., Smith, S., Joshi, A., Haimbach, R., Clark, D., Li, Y., Hua, J., McKelvey, T., Ou, Y., et al. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00036 · Cited by 25
“The mAb was isolated from the Cambridge Antibody Technology (CAT) scFv antibody library and has high affinity and specificity for IsdB.”
BackgroundMethod
Metadata
- Authors
- Vernachio, J. H., Bayer, A. S., Ames, B., Bryant, D., Prater, B. D., Syribeys, P. J., Gorovits, E. L., & Patti, J. M.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2006-02
- Volume
- 50
- Issue
- 2
- Pages
- 511-518
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2007624327
- Cited by
- 68
- References
- 3
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human Immunoglobulin G Recognizing Fibrinogen-Binding Surface Proteins Is Protective against both Staphylococcus aureus and Staphylococcus epidermidis Infections In Vivo. https://app.cochat.ai/papers/10.1128/aac.50.2.511-518.2006
- The paper
- Vernachio, J. H., Bayer, A. S., Ames, B., Bryant, D., Prater, B. D., Syribeys, P. J., Gorovits, E. L., & Patti, J. M. (2006). Human Immunoglobulin G Recognizing Fibrinogen-Binding Surface Proteins Is Protective against both Staphylococcus aureus and Staphylococcus epidermidis Infections In Vivo. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.50.2.511-518.2006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.